FDA Should Review Potentially Deceiving Television Advertisements For Johnson & Johnson Stent, NEJM Opinion Piece Says
May 17th 2008Drug InformationCardiovascular
Television advertisements for Johnson & Johnson’s drug-coated Cypher stent might deceive consumers and should be reviewed by FDA, according to an opinion piece published Wednesday in the New England Journal of Medicine, the
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.